Screener
ClearPoint Neuro CLPT Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by ClearPoint Neuro in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: ClearPoint Neuro’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221890
| Line item | March 31, 2026 / (Unaudited) | December 31, 2025 |
|---|---|---|
| Total assets | $93,416 | $97,747 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $2,330 | $1,256 |
| Accrued compensation | 2,977 | 4,360 |
| Other accrued liabilities | 2,125 | 2,786 |
| Operating lease liabilities, current portion | 234 | 694 |
| Contract liabilities, current portion | 1,814 | 1,669 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is ClearPoint Neuro's accounts payable?
- ClearPoint Neuro (CLPT) reported accounts payable of $2.33M in Q1 2026.
- How has ClearPoint Neuro's accounts payable changed year-over-year?
- ClearPoint Neuro's accounts payable increased by 91.6% year-over-year, from $1.22M to $2.33M.
- What is the long-term trend for ClearPoint Neuro's accounts payable?
- Over 5 years (2020 to 2025), ClearPoint Neuro's accounts payable has grown at a 33.2% compound annual growth rate (CAGR), from $300K to $1.26M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about ClearPoint Neuro's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude